EU’s top court clarifies when a patent settlement agreement can infringe EU antitrust rules

Published date11 February 2020
Subject MatterPatents,Settlement Agreements,Pharmaceutical Patents,EU,UK Competition and Markets Authority (CMA),European Court of Justice (ECJ),Competition Appeals Tribunal (CAT),Antitrust Provisions
AuthorFrancesca Miotto,Nele De Backer
Law FirmAllen & Overy LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT